Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA OIP5-AS1 modulates the proliferation and apoptosis of Jurkat cells by sponging miR-181c-5p to regulate IL-7 expression in myasthenia gravis. | PeerJ | 2022 | 35602889 | PubTator, text mining | PubMed |
| Thymectomy in Myasthenia Gravis: A Narrative Review. | Saudi J Med Med Sci | 2022 | 35602390 | PubTator, text mining | PubMed |
| Pure white cell aplasia an exceptional condition in the immunological conundrum of thymomas: Responses to immunosuppression and literature review. | Clin Case Rep | 2022 | 35582161 | PubTator, text mining | PubMed |
| Identification of SMIM1 and SEZ6L2 as Potential Biomarkers for Genes Associated with Intervertebral Disc Degeneration in Pyroptosis. | Dis Markers | 2022 | 35578687 | PubTator, text mining | PubMed |
| Biomarkers in Rare Diseases 2.0. | Int J Mol Sci | 2022 | 35562973 | PubTator, text mining | PubMed |
| Is hypnotic assessment relevant to neurology? | Neurol Sci | 2022 | 35562556 | PubTator, text mining | PubMed |
| Synthesis of mixed musks via Eschenmoser-Tanabe fragmentation, enyne metathesis and Diels-Alder reaction as key steps. | RSC Adv | 2022 | 35558836 | PubTator, text mining | PubMed |
| Single-nucleus cross-tissue molecular reference maps toward understanding disease gene function. | Science | 2022 | 35549429 | PubTator, text mining | PubMed |
| Corticosteroid Treatment-Resistance in Myasthenia Gravis. | Front Neurol | 2022 | 35547366 | PubTator, text mining | PubMed |
| Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study. | Neuropsychiatr Dis Treat | 2022 | 35535211 | PubTator, text mining | PubMed |
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies. | Lancet Rheumatol | 2022 | 35527808 | PubTator, text mining | PubMed |
| Lymphoplasma Exchange Improves Myasthenia Gravis Exacerbations: A Retrospective Study in a Chinese Center. | Front Immunol | 2022 | 35514988 | PubTator, text mining | PubMed |
| Rituximab in Rasmussen's encephalitis: A single center experience and review of the literature. | Epilepsy Behav Rep | 2022 | 35509501 | PubTator, text mining | PubMed |
| New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome. | Cell Mol Life Sci | 2022 | 35504983 | PubTator, text mining | PubMed |
| Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients. | J Neurol | 2022 | 35503373 | PubTator, text mining | PubMed |
| Mapping the epithelial-immune cell interactome upon infection in the gut and the upper airways. | NPJ Syst Biol Appl | 2022 | 35501398 | PubTator, text mining | PubMed |
| A 47-Year-Old Japanese Woman with Symptoms of Increased Salty and Reduced Sweet Taste Perception Preceding a Diagnosis of Thymoma-Associated Myasthenia Gravis. | Am J Case Rep | 2022 | 35491487 | PubTator, text mining | PubMed |
| Exposure to 3,3',4,4',5-Pentachlorobiphenyl (PCB126) Causes Widespread DNA Hypomethylation in Adult Zebrafish Testis. | Toxicol Sci | 2022 | 35477799 | PubTator, text mining | PubMed |
| Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron Disease. | Acta Neuropathol Commun | 2022 | 35468848 | PubTator, text mining | PubMed |
| Association Between Clinical Factors and Result of Immune Checkpoint Inhibitor Related Myasthenia Gravis: A Single Center Experience and Systematic Review. | Front Neurol | 2022 | 35463153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=44